AI Model for Prostate Biopsies Predicts Cancer Survival.

Sandeman, Kevin; Blom, Sami; Koponen, Ville; Manninen, Anniina; Juhila, Juuso; Rannikko, Antti; Ropponen, Tuomas; Mirtti, Tuomas

Sandeman, Kevin; Blom, Sami; Koponen, Ville; Manninen, Anniina; Juhila, Juuso; Rannikko, Antti; Ropponen, Tuomas; Mirtti, Tuomas.

Afiliação

Sandeman K; Medicum and Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, P.O. Box 63, 00014 Helsinki, Finland.
Blom S; Department of Pathology, Division of Laboratory Medicine, Skåne University Hospital, Jan Waldenström Gata 59, 20502 Malmö, Sweden.
Koponen V; Aiforia Technologies Plc., Tukholmankatu 8, 00290 Helsinki, Finland.
Manninen A; Aiforia Technologies Plc., Tukholmankatu 8, 00290 Helsinki, Finland.
Juhila J; Aiforia Technologies Plc., Tukholmankatu 8, 00290 Helsinki, Finland.
Rannikko A; Aiforia Technologies Plc., Tukholmankatu 8, 00290 Helsinki, Finland.
Ropponen T; Medicum and Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, P.O. Box 63, 00014 Helsinki, Finland.
Mirtti T; Department of Urology, Helsinki University Hospital, P.O. Box 340, 00029 Helsinki, Finland.

Diagnostics (Basel) ; 12(5)2022 Apr 20.

Article em En | MEDLINE | ID: mdl-35626187

Palavras-chave

artificial intelligence; biopsy; deep learning; grade group; prostate cancer; radical prostatectomy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Diagnostics (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Finlândia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google